The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated antitumor activity and safety of FPA144, an ADCC-enhanced, FGFR2b isoform-specific monoclonal antibody, in patients with FGFR2b+ gastric cancer.
 
Daniel V.T. Catenacci
Honoraria - Amgen; Foundation Medicine; Genentech/Roche; Genmab; Guardant Health; Lilly; NantWorks; OncoPlex Diagnostics; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Genentech/Roche; OncoPlex Diagnostics
Speakers' Bureau - Foundation Medicine; Guardant Health; Lilly; NantWorks
Research Funding - Genentech; OncoPlex Diagnostics
 
Sun Young Rha
No Relationships to Disclose
 
Yung-Jue Bang
Consulting or Advisory Role - Five Prime Therapeutics
Research Funding - Five Prime Therapeutics
 
Zev A. Wainberg
Consulting or Advisory Role - Amgen; Array BioPharma; Five Prime Therapeutics; Sirtex Medical
Speakers' Bureau - Genentech
Research Funding - Biomarin (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Amgen; Genentech
 
Joseph Chao
Consulting or Advisory Role - Bayer; Boston Biomedical; Five Prime Therapeutics; Lilly
Research Funding - Merck (Inst)
 
Keun Wook Lee
No Relationships to Disclose
 
Wolfgang Michael Korn
Stock and Other Ownership Interests - OncoCyte
Honoraria - Genentech/Roche
Consulting or Advisory Role - ARMO Biosciences (Inst); Foundation Medicine; Merrimack
Research Funding - Merrimack (Inst)
Patents, Royalties, Other Intellectual Property - Exelixis
Travel, Accommodations, Expenses - Merrimack
 
Yeul Hong Kim
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Macrogenics (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst)
 
Eun-Kee Song
No Relationships to Disclose
 
Chang-Fang Chiu
No Relationships to Disclose
 
Chia-Jui Yen
No Relationships to Disclose
 
Jordan Berlin
Consulting or Advisory Role - Aduro Biotech; ARMO BioSciences; Boston Biomedical; Celgene; Cornerstone Pharmaceuticals; EMD Serono; Exelixis; Five Prime Therapeutics; Genentech/Roche; Janssen Oncology; Opsona Therapeutics; Pharmacyclics; Pierre Fabre; Symphony Evolution; Vertex
Research Funding - Abbvie (Inst); Bayer (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Incyte (Inst); Loxo (Inst); Merrimack (Inst); Novartis (Inst); OncoMed (Inst); Pharmacyclics (Inst); Symphony Evolution (Inst); Taiho Pharmaceutical (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Boston Biomedical; Celgene; Genentech/Roche; Janssen Oncology; vertex
Other Relationship - AstraZeneca; Momenta Pharmaceuticals; Symphony Evolution
 
Jin-Soo Kim
Stock and Other Ownership Interests - Chong Kun Dang Pharmaceutical; DAEHWA Pharmaceutical
Honoraria - CJ Healthcare; Merck
Consulting or Advisory Role - CJ Healthcare; DAEHWA Pharmaceutical; Lilly
Research Funding - AstraZeneca; Boehringer Ingelheim; Chong Kun Dang Pharmaceutical; CJ Healthcare; Hanmi; Lilly; Sanofi
 
Robert S. Sikorski
Employment - Five Prime Therapeutics
Leadership - Five Prime Therapeutics
Stock and Other Ownership Interests - Five Prime Therapeutics
 
Helen Collins
Employment - Five Prime Therapeutics
Stock and Other Ownership Interests - Five Prime Therapeutics
 
Lee Clark
Employment - Five Prime Therapeutics
Stock and Other Ownership Interests - Five Prime Therapeutics
 
Sandeep P. Inamdar
Employment - Acerta Pharma; Onyx
Stock and Other Ownership Interests - Amgen; Gilead Sciences; GlaxoSmithKline; Onyx
 
Charlie Zhang
Employment - Five Prime Therapeutics
Stock and Other Ownership Interests - Five Prime Therapeutics
 
Jeeyun Lee
No Relationships to Disclose